Literature DB >> 29528656

Physical Stability and Dissolution Behavior of Ketoconazole-Organic Acid Coamorphous Systems.

Michelle Fung1, Ka Rlis Be Rziņš1, Raj Suryanarayanan1.   

Abstract

In an earlier investigation, coamorphous systems of ketoconazole (KTZ) prepared with each oxalic (OXA), tartaric (TAR), citric (CIT), and succinic (SUC) acid, revealed drug-acid ionic or hydrogen bonding interactions in the solid-state (Fung et al, Mol. Pharmaceutics, 2018, 15 (3), 1052-1061). We showed that the drug-acid interactions in KTZ-TAR were the strongest, followed by KTZ-OXA, KTZ-CIT, and KTZ-SUC. In this study, we investigated the crystallization propensity and dissolution behavior of the KTZ-acid coamorphous systems. When in contact with water (either as water vapor or as aqueous phosphate buffer), while KTZ-CIT and KTZ-TAR were physically stable and resisted crystallization, KTZ-SUC and KTZ-OXA crystallized more readily than KTZ alone. The dissolution performances of the coamorphous systems were compared using the area under the curve (AUC) obtained from the concentration-time profiles. KTZ-OXA exhibited the highest AUC, while it was about the same for KTZ-TAR and KTZ-CIT and the lowest for KTZ-SUC. The enhancement in dissolution appeared to become more pronounced as the strength of the acid (OXA > TAR > CIT > SUC) increased. Coamorphization with acid caused at least a two-fold increase in AUC when compared with amorphous KTZ. The decrease in pH of the diffusion layer of the dissolving solid, brought about by the acid, is at least partially responsible for the dissolution enhancement. In addition, the particles of KTZ-OXA, KTZ-TAR, and KTZ-CIT were much smaller than those of KTZ-SUC. The consequent effect on surface area could be another contributing factor to the initial dissolution behavior.

Entities:  

Keywords:  amorphous; coamorphous; crystallization; dissolution; physical stability; solid dispersions

Mesh:

Substances:

Year:  2018        PMID: 29528656     DOI: 10.1021/acs.molpharmaceut.8b00035

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

Review 1.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

Review 2.  Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.

Authors:  Qin Shi; Yanan Wang; Sakib M Moinuddin; Xiaodong Feng; Fakhrul Ahsan
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

3.  Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability.

Authors:  Zhaomeng Wang; Mengchi Sun; Tian Liu; Zisen Gao; Qing Ye; Xiao Tan; Yanxian Hou; Jin Sun; Dun Wang; Zhonggui He
Journal:  Asian J Pharm Sci       Date:  2018-11-14       Impact factor: 6.598

4.  Influence of the pK a Value of Cinnamic Acid and P-Hydroxycinnamic Acid on the Solubility of a Lurasidone Hydrochloride-Based Coamorphous System.

Authors:  Yi Hu; Yujie Guo; Bin Li; Renjie Xu; Xiaoping Fang; Yan Cao; Zifan Liu; Cuiping Jiang; Shan Lu
Journal:  ACS Omega       Date:  2021-01-22

5.  Co-amorphous palbociclib-organic acid systems with increased dissolution rate, enhanced physical stability and equivalent biosafety.

Authors:  Man Zhang; Xinnuo Xiong; Zili Suo; Quan Hou; Na Gan; Peixiao Tang; Xiaohui Ding; Hui Li
Journal:  RSC Adv       Date:  2019-01-29       Impact factor: 4.036

6.  Selection of a Water-Soluble Salt Form of a Preclinical Candidate, IIIM-290: Multiwell-Plate Salt Screening and Characterization.

Authors:  Vikas Kumar; Sandip B Bharate; Ram A Vishwakarma; Sonali S Bharate
Journal:  ACS Omega       Date:  2018-07-27

7.  Amorphous solid dispersion formation via solvent granulation - A case study with ritonavir and lopinavir.

Authors:  Niraj S Trasi; Sonal Bhujbal; Qi Tony Zhou; Lynne S Taylor
Journal:  Int J Pharm X       Date:  2019-11-12

Review 8.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.

Authors:  Jingwen Liu; Holger Grohganz; Korbinian Löbmann; Thomas Rades; Nele-Johanna Hempel
Journal:  Pharmaceutics       Date:  2021-03-15       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.